GSKNEUTRAL

GSK Revenue Growth (YoY) Analysis

5.3%

Updated 299h ago·SEC filings & market data

Key Takeaway

Revenue growth year-over-year measures how much sales increased compared to the same period last year; GSK's 5.3% means its revenue expanded by that rate.

Sector Performance

33th percentile

GSK

5.3%

Sector Median

9.2%

Sector Avg

14.7%

Prior Period

1.5%(Jun 2026)

↑ Improving
📊

Deep Analysis

Revenue growth year-over-year measures how much sales increased compared to the same period last year; GSK's 5.3% means its revenue expanded by that rate.

This trails the sector median of 8.7%, placing GSK at the 35th percentile, meaning most peers grow faster. The trend direction is not available, with both the year-over-year change and quarter-over-quarter change marked as N/A, leaving no basis to judge acceleration or deceleration. With a growth level below average and no trend data, the near-term revenue trajectory is uncertain, adding moderate risk rather than a clear opportunity. An investor would need additional data, such as product launches or patent expiries, to assess whether the underperformance will persist. This metric aligns with the overall NEUTRAL verdict, as it neither signals a decisive correction nor a strong recovery. The below-median growth is a mild negative, but without trend information it does not justify a bearish stance.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about GSK?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are GSK's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: FCX (-7.3%), INSP (-7.6%), FOX (-8.6%), NVR (-10.5%), HES (-11.2%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master GSK's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full GSK research report

Free account — no credit card

GSK

5.3%

Sector Median

9.2%

Sector Avg

14.7%

How GSK's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.